Vassiliki Saloura

AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma

Toni M. Brand, Mari Iida, Andrew P. Stein et al. · Clinical Cancer Research · 2015 · 117 citations · Full text

Medicine, Molecular Biology, Oncology +16

Expression of IFN-β Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma

Candice Willmon, Vassiliki Saloura, Zvi G. Fridlender et al. · Cancer Research · 2009 · 112 citations · Full text

Medicine, Immunology, Oncology +17

WHSC1 Promotes Oncogenesis through Regulation of NIMA-Related Kinase-7 in Squamous Cell Carcinoma of the Head and Neck

Vassiliki Saloura, Hyun‐Soo Cho, Kazuma Kiyotani et al. · Molecular Cancer Research · 2014 · 101 citations · Full text

Medicine, Cancer Biology, Oncology +17

An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck

Vassiliki Saloura, Ezra E.W. Cohen, Lisa Licitra et al. · Cancer Chemotherapy and Pharmacology · 2014 · 86 citations

Medicine, Oncology, Pharmacotherapy +17

Immune profiles in primary squamous cell carcinoma of the head and neck

Vassiliki Saloura, Evgeny Izumchenko, Zhixiang Zuo et al. · Oral Oncology · 2019 · 73 citations · Full text

Medicine, Immunology, Oncology +10